President Trump's Marijuana Fix? DEA’s Program Exposed: Promises Made, Promises Not Kept

August 17, 2025 6:00 AM

President Trump's decision to potentially reschedule marijuana is the first serious step in decades to break through the bureaucratic logjam that has kept patients and scientists waiting. For years, the DEA has promised a functional marijuana research program. For years, those promises have been broken. DEA's Promises on PaperIn its Final Rule (85 Fed. Reg. 82333, Dec. 18, 2020), the DEA pledged that marijuana manufacturing licenses would be...

Read more

Flush Factor Plus Safety Report: EXPOSING Fake Claims, Reviews, Leg & Joint Health Formula

August 16, 2025 11:57 AM

With more adults experiencing leg swelling, joint stiffness, and circulation issues due to sedentary lifestyles, the demand for natural joint and fluid support has skyrocketed. Flush Factor Plus has recently emerged as a popular solution, promising to target the root cause of leg swelling by regulating the antidiuretic hormone arginine vasopressin (AVP) and supporting healthy circulation.However, with the rise of counterfeit products and...

Read more

Epic UGM 2025 Survival Guide: Insider Tips for Vendors, Storytellers, and Market Watchers

August 16, 2025 11:00 AM

Every August, Verona becomes the gathering place for thousands of Epic users, providers, and partners. UGM isn't a typical trade show , it's more like a community meet-up where leaders come to hear Epic's roadmap, share ideas, and compare notes. For vendors, PR teams, and media, it's a chance to understand where the conversation is heading and how to connect without disrupting the flow.For vendors and the PR, content, and marketing teams that...

Read more

Audifort Reviews & Complaints: Real User Feedback About Tinnitus, Hearing Risks, and Official Purchase Guide

August 15, 2025 5:05 PM

If you've been struggling with tinnitus, age-related hearing loss, or the constant frustration of ringing and muffled sounds, you're not alone. With hundreds of supplements flooding the market, it's hard to know which ones actually work, or which ones are scams. That's why Audifort has caught attention in 2025: it's marketed as a scientifically backed, multi-layered hearing support formula, promising to address auditory nerve health,...

Read more

BookJane Partnership Announcement

August 15, 2025 3:05 PM

As Canadian healthcare providers face ongoing staffing challenges, BookJane, a leading provider of workforce management technology, and Nexim Healthcare Consultants Inc., a trusted name in healthcare staffing for more than 14 years, have formed a strategic partnership to enhance scheduling, shift fulfillment, and workforce deployment across assisted living, long-term care, hospitals, shelters and the community living support - health & social...

Read more

Bausch Health Announces Increase in Shareholding by its Chairperson of the Board and Board Changes

August 15, 2025 2:30 PM

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) ("Bausch Health" or the "Company") today announced that Paulson Capital Inc. and certain affiliates and managed funds have increased their ownership of the Company's common shares.The increase reflects the acquisition by Paulson Capital Inc. and certain affiliates and managed funds of the net long position of 34,721,118 common shares previously held by Mr. Carl C. Icahn and his affiliates...

Read more

Allied OMS Expands Footprint in Texas Hill Country with Addition of Kerrville Oral & Maxillofacial Surgery

August 15, 2025 1:16 PM

Allied OMS continues its strategic expansion in Texas with the addition of Kerrville Oral & Maxillofacial Surgery. This partnership strengthens Allied OMS's presence in the Hill Country region, which encompasses the Austin and San Antonio markets.Kerrville Oral & Maxillofacial Surgery is renowned for its commitment to providing a superior patient experience. The practice offers a comprehensive range of services, including anesthesia, dental...

Read more

Ascelia Pharma Updates Timeline for Submission of the Orviglance NDA

August 15, 2025 12:40 PM

Ascelia Pharma (STO:ACE) - Ascelia Pharma AB (publ) (ticker:ACE), a biotech focused on improving the life of people living with rare cancer conditions, today provided additional information regarding the submission of the New Drug Application (NDA) for Orviglance® to the US Food and Drug Administration (FDA).The NDA file is essentially complete. The final electronic configuration of the file, required to meet FDA submission standards...

Read more

Seven Underreported, AI-Infused Healthcare IT Segments Poised for Accelerated Breakout Growth Through 2026

August 15, 2025 10:00 AM

Results of a flash survey of 126 verified venture capital, private equity, investment banking, and healthcare M&A professionals conducted by Black Book has surfaced seven AI-enabled healthcare IT segments that remain materially underpenetrated yet exhibit compelling fundamentals for outsized returns through 2026.These opportunity clusters spanning automation, clinical operations optimization, decentralized trial enablement, and device ecosystem...

Read more

Real Game Used Brings High-Tech & Human Expertise Together to Protect Collectors Worldwide

August 15, 2025 9:17 AM

Real Game Used (www.realgameused.com), a subsidiary of Medical Care Technologies Inc. (OTC Pink:MDCE), is redefining memorabilia authentication by offering two distinct types of verification: Photo Match Authentication and Item Analysis Authentication.Real Game Used authenticates game-worn sports memorabilia, screen-worn/used movie and television memorabilia, and music and entertainment celebrity-worn memorabilia. The company's Photo Match...

Read more

Onco-Innovations Announces 90% of $0.60 Warrants Have Been Exercised

August 15, 2025 9:15 AM

Onco-Innovations Limited (CBOE CA:ONCO)(Frankfurt:W1H, WKN: A3EKSZ)(OTCQB:ONNVF) ("Onco" or the "Company") is pleased to announce the successful execution of a key component of its capital strategy, as over 90% of the Company's outstanding common share purchase warrants priced at $0.60 have now, to date, been exercised, resulting in an additional inflow of capital and confirming the effectiveness of the Company's internal financing...

Read more

Ambience Healthcare Joins Epic Toolbox, Unlocking Advanced AI Functionality Within Haiku for Epic Customers

August 15, 2025 9:05 AM

Ambience Healthcare, a leading AI platform for documentation, coding, and clinical documentation integrity (CDI), today announced it has joined Epic's Toolbox program for Ambient Voice Recognition.Joining the Toolbox program will expand the availability of Ambience's AI-powered documentation capabilities to a broader range of Epic customers and launch Ambience's latest integration with Epic's Ambient Module and Haiku.This latest iteration of...

Read more

CNS Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Corporate Update

August 15, 2025 8:05 AM

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today reported its financial results for the second quarter ended June 30, 2025 and provided a corporate update."Every decision we make is grounded in our science and driven by a sense of urgency and responsibility to the...

Read more

Nutrishare Acquires Select Coram(R) Pharmacy Assets to Expand Services Nationwide and Open New Pharmacy in Arizona

August 15, 2025 8:00 AM

Nutrishare, the nation's only provider exclusively focused on home Total Parenteral Nutrition (TPN), today announced the acquisition of select pharmacy home infusion assets from Coram®, a CVS Health® company. This acquisition follows Coram's previously announced decision to close local pharmacies and establish three national Coram hubs to better serve its patients and providers. This acquisition enables Nutrishare to expand its reach, enhancing...

Read more

CureVac Announces Financial Results for the Second Quarter and First Half of 2025 and Provides Business Updates

August 15, 2025 7:50 AM

CureVac N.V. (Nasdaq:CVAC), a pioneering multinational biotech company developing a new class of transformative medicines based on messenger RNA (mRNA), today announced financial results for the second quarter and first half of 2025 and provided a business update."By entering into a definitive purchase agreement with BioNTech, we intend to unite two highly complementary German companies that are well positioned to drive long-term shareholder...

Read more

Encision Reports First Quarter Fiscal Year 2026 Results

August 15, 2025 5:00 AM

Encision Inc. (OTC PINK:ECIA), a medical device company owning patented Active Electrode Monitoring (AEM®) Technology that prevents dangerous radiant energy burns in minimally invasive surgery, today announced financial results for its fiscal 2025 first quarter that ended June 30, 2025.The Company posted quarterly product net revenue of $1.49 million and service net revenue of $110 thousand, or total net revenue of $1.6 million for a quarterly...

Read more

The Untold Truth About President Trump's Marijuana Rescheduling

August 15, 2025 5:00 AM

President Donald Trump has signaled he is open to reclassifying marijuana under federal law, particularly for medical purposes, calling it a "very complicated subject" but acknowledging he's heard "good things" for pain and chronic disease. If his administration follows through - especially with a move to separate recreational marijuana from FDA-regulated medical cannabis - it could trigger a seismic shift in the industry. For most cannabis...

Read more

Hemogenyx Pharmaceuticals PLC - Third Patient Treated with HG-CT-1 CAR-T Therapy

August 15, 2025 2:00 AM

Hemogenyx Pharmaceuticals plc (LSE:HEMO) is pleased to announce that the third patient has been successfully treated as part of the Company's ongoing Phase I clinical trial of HG-CT-1, its proprietary CAR-T cell therapy for relapsed or refractory acute myeloid leukemia ("R/R AML") in adults.Treatment of this patient, the final participant in the first adult dose cohort, was made possible after the Company secured special permission from the U.S....

Read more

Investors Signal New Era of Deal Discipline in Healthcare IT: Post-Boom Challenges and Untapped Opportunities Emerge in H2 2025

August 14, 2025 5:15 PM

Amidst persistent headlines about failed M&A in digital health, a new Black Book Research flash survey conducted with over 100 senior healthcare IT investors reveals a more complex and unexpected set of priorities driving investment decisions as the sector redefines value in a post-pandemic, post-AI hype cycle world.Unlike recent "deal killer" analyses, the Black Book poll surfaces underreported investor concerns and future-facing diligence...

Read more

SafeHeal(R) Receives European Marketing Approval Under MDR for Colovac(R) Anastomosis Protection Technology

August 14, 2025 4:45 PM

SafeHeal®, a leading innovator in the field of colorectal cancer surgery, today announced that it has been granted European Union marketing approval for its Colovac device under the new Medical Device Regulation (EU MDR 2017/745, Medical Devices, Annex IX Chapter I). This significant milestone confirms the company's compliance with the EU's rigorous safety and performance standards, enabling commercial distribution of Colovac across the European...

Read more